Literature DB >> 28541024

The clinical significance of neoadjuvant chemotherapy in improving the drug resistance of osteosarcoma.

Yongxian Wan1, Lili Xu2, Naiqiang Zhuo3, Jianhua Ge3, Ge Chen3, Xiao-Bo Lu3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28541024     DOI： 10.23736/S0026-4806.17.05122-9

Source DB:  PubMed          Journal:  Minerva Med        ISSN： 0026-4806            Impact factor:   4.806


× No keyword cloud information.
  4 in total

1.  Necrosis of osteosarcoma cells induces the production and release of high-mobility group box 1 protein.

Authors:  Jiyu Yang; Zhiqiang Ma; Yanlong Wang; Zengkun Wang; Youwei Tian; Yingchao Du; Wei Bian; Yongfu Duan; Jianyu Liu
Journal:  Exp Ther Med       Date:  2017-11-01       Impact factor: 2.447

2.  Lumbar spinal canal osteosarcoma: A case report.

Authors:  De-Jian Chen; Qi Lai; Jianghao Zhu; Zongmiao Wan; Hucheng Liu; Min Dai; Runsheng Guo; Bin Zhang
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

3.  LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis.

Authors:  Dong Fu; Chunwen Lu; Xingzhou Qu; Peng Li; Kai Chen; Liancheng Shan; Xiaodong Zhu
Journal:  Aging (Albany NY)       Date:  2019-10-10       Impact factor: 5.682

4.  β-Elemene Enhances the Sensitivity of Osteosarcoma Cells to Doxorubicin via Downregulation of Peroxiredoxin-1.

Authors:  Shaochun Zhang; Weichun Guo
Journal:  Onco Targets Ther       Date:  2021-06-03       Impact factor: 4.147
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.